Correction to: European Journal of Pediatrics (2026) 185:314
https://doi.org/10.1007/s00431-026-06958-8
In Table 1 of the original publication, errors were identified.
Table 1 Clinical characteristics
| Clinical characteristics | Total study population (n = 51) | Neonates with methemoglobinemia (n = 24) | Neonates without methemoglobinemia (n = 27) |
|---|---|---|---|
| Gestational age, weeks.days, median (IQR) | 38.1 (37.1–39.1) | 40.0 (38.1–40.6) | 38.3 (34.4–40.3)* |
| Preterm (GA < 36 weeks), n (%) | 10 (20) | 1 (4) | 8 (30) |
| Female, n (%) | 26 (50) | 11 (46) | 15 (56) |
| Birthweight, grams, mean (95% CI) | 3385 (2734–3800) | 2580 (3309–3850) | 2870 (2478–3262) |
| Apgar score, Median (IQR) | |||
| 5 min | 7 (3–9)† | 9 (1–8) | 4 (1–8)§ |
| 10 min | 9 (5–9)‡ | 9 (7–10) | 6 (2–9) |
| Seizure etiology, n (%) | |||
| HIE | 21 (41) | 2 (13) | 19 (70) |
| Arterial ischemic stroke | 6 (12) | 5 (21) | 1 (4) |
| Hemorrhagic stroke | 8 (16) | 7 (29) | 1 (4) |
| CNS infection | 7 (15) | 4 (17) | 3 (11) |
| Metabolic disorder | 4 (8) | 3 (13) | 1 (4) |
| Genetic condition | 4 (8) | 2 (8) | 2 (7) |
| LDC regimen, n (%) | |||
| I (22 h, 49.25 mg/kg) | 3 (6) | 0 (0) | 3 (11) |
| II (22 h, 62 mg/kg) | 2 (4) | 3 (13) | 2 (7) |
| III (30 h, 110 mg/kg) | 35 (69) | 21 (87) | 11 (41) |
| IV (18 h, 50 mg/kg) | 11 (21) | 0 (0) | 11 (41) |
| Therapeutic hypothermia, n (%) | 11 (52)|| | 0 (0) | 11 (41) |
| PPHN for which NO was used, n (%) | 8 (16) | 5 (21) | 3 (11) |
| Sepsis, n (%) | 4 (6) | 1 (4) | 3 (11) |
| Neonatal death, n (%) | 29 (40) | 7 (29) | 21 (78) |
*1 infant missing: term pregnancy (exact GA unknown)
†4 neonates missing
‡6 neonates missing
§1 infant missing
||Among 21 neonates with HIE
Published form:
Corrected form:
Table 1 Clinical characteristics
| Clinical characteristics | Total study population (n = 51) | Neonates with methemoglobinemia (n = 24) | Neonates without methemoglobinemia (n = 27) |
|---|---|---|---|
| Gestational age, weeks.days, median (IQR) | 38.1 (37.1–39.1) | 40.0 (38.1–40.6) | 38.3 (34.4–40.3)* |
| Preterm (GA < 36 weeks), n (%) | 10 (20) | 1 (4) | 8 (30) |
| Female, n (%) | 26 (50) | 11 (46) | 15 (56) |
| Birthweight, grams, mean (95% CI) | 3385 (2734–3800) | 2580 (3309–3850) | 2870 (2478–3262) |
| Apgar score, Median (IQR) | |||
| 5 min | 7 (3–9)† | 9 (1–8) | 4 (1–8)§ |
| 10 min | 9 (5–9)‡ | 9 (7–10) | 6 (2–9) |
| Seizure etiology, n (%) | |||
| HIE | 21 (41) | 2 (13) | 19 (70) |
| Arterial ischemic stroke | 6 (12) | 5 (21) | 1 (4) |
| Hemorrhagic stroke | 8 (16) | 7 (29) | 1 (4) |
| CNS infection | 7 (15) | 4 (17) | 3 (11) |
| Metabolic disorder | 4 (8) | 3 (13) | 1 (4) |
| Genetic condition | 4 (8) | 2 (8) | 2 (7) |
| LDC regimen, n (%) | |||
| I (22 h, 49.25 mg/kg) | 3 (6) | 0 (0) | 3 (11) |
| II (22 h, 62 mg/kg) | 5 (10) | 3 (13) | 2 (7) |
| III (30 h, 110 mg/kg) | 32 (63) | 21 (87) | 11 (41) |
| IV (18 h, 50 mg/kg) | 11 (21) | 0 (0) | 11 (41) |
| Therapeutic hypothermia, n (%) | 11 (52)|| | 0 (0) | 11 (41) |
| PPHN for which NO was used, n (%) | 8 (16) | 5 (21) | 3 (11) |
| Sepsis, n (%) | 4 (6) | 1 (4) | 3 (11) |
| Neonatal death, n (%) | 29 (40) | 7 (29) | 21 (78) |
*1 infant missing: term pregnancy (exact GA unknown)
†4 neonates missing
‡6 neonates missing
§1 infant missing
||Among 21 neonates with HIE
The original article has been corrected.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.